A case of pulmonary edema due to guanfacine intoxication with measurement of serum guanfacine concentrations
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 48 (12) , 641-644
Abstract
Guanfacine hydrochloride extended-release (GXR) is used to treat attention deficit hyperactivity disorder. It is a selective α2A-adrenorecepor agonist that was reported to cause QT prolongation and hypotension in the event of overdosing. We report the case of a 17-year-old man who took 226 tablets of GXR 3 mg for attempted suicide. He was found complaining of dyspnea, and emergency medical services were called. When the patient was transferred to our hospital, his Glasgow coma scale was 12 (E4V3M5). He was agitated and hypoxemic. He was intubated for invasive mechanical ventilation under sedation. His chest X-ray and computed tomography scan showed pulmonary edema. Transthoracic echocardiography showed markedly reduced cardiac function. His serum guanfacine concentration peaked on day 3 after admission. His pulmonary edema improved quickly after a decrease in serum guanfacine concentration, but cardiac decompensation persisted for about 1 month. This case reveals that the decline in cardiac function after guanfacine intoxication is prolonged even after its serum concentration has decreased.Keywords
This publication has 12 references indexed in Scilit:
- Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edemaThe American Journal of Emergency Medicine, 2021
- Autonomic instability in a dehydrated child on guanfacine: Case report and literature reviewPaediatrics & Child Health, 2017
- Prolonged Bradycardia and Hypotension Following Guanfacine Extended Release OverdoseJournal of Child and Adolescent Psychopharmacology, 2014
- Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotensionClinical Toxicology, 2010
- A phase i, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adultsClinical Therapeutics, 2007
- Epidemiology and Toxicity of Pediatric Guanfacine ExposuresAnnals of Pharmacotherapy, 2002
- Central Hypotensive Effects of the α 2a -Adrenergic Receptor SubtypeScience, 1996
- Comparison of the Binding Activities of Some Drugs on α2A, α2Band α2C‐Adrenoceptors and Non‐Adrenergic Imidazoline Sites in the Guinea PigBasic & Clinical Pharmacology & Toxicology, 1995
- The Bioavailability and Pharmacokinetics of Guanfacine After Oral and Intravenous Administration to Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- Mechanism of the Antihypertensive Effect of Alpha2-AgonistsJournal of Cardiovascular Pharmacology, 1985